Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Teugels, Erik" or (type any "bookEditor issueEditor" and editor="Teugels, Erik")

Add to list
The BRCA1 c. 5096G > A p.Arg1699Gln (R1699Q) intermediate risk variant : breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

Setareh Moghadasi, Huong D Meeks, Maaike PG Vreeswijk, Linda AM Janssen, Ake Borg, Hans Ehrencrona, Ylva Paulsson-Karlsson, Barbara Wappenschmidt, Christoph Engel, Andrea Gehrig, et al.

(2018) JOURNAL OF MEDICAL GENETICS. 55(1). p.15-20
Add to list
- Journal Article
- A1
- open access
The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation : efficacy and safety

Erica Sermijn, Liesbeth Delesie (UGent) , Ellen Deschepper (UGent) , Ingrid Pauwels, Maryse Bonduelle, Erik Teugels and Jacques De Greve

(2016) FAMILIAL CANCER. 15(2). p.155-162
Add to list
- Journal Article
- A1
- open access
Prospective evaluation of first-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation : a multicenter academic phase II study in Caucasian patients (FIELT)

Jacques De Grève, Jan Van Meerbeeck (UGent) , Johan F Vansteenkiste, Lore Decoster, Anne-Pascale Meert, Peter Vuylsteke, Christian Focan, Jean-Luc Canon, Yves Humblet, Guy Berchem, et al.

(2016) PLOS ONE. 11(3).
Add to list
Combined inhibition of rho-associated protein kinase and EGFR suppresses the invasive phenotype in EGFR-dependent lung cancer cells

Ijeoma Adaku Umelo, Olivier De Wever (UGent) , Peter Kronenberger, Alfiah Noor, Erik Teugels, Gang Chen, Marc Bracke (UGent) and Jacques De Grève

(2015) LUNG CANCER. 90(2). p.167-174
Add to list
- Journal Article
- A1
- open access
Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade

Ijeoma Adaku Umelo, Olivier De Wever (UGent) , Peter Kronenberger, Jan Van Deun (UGent) , Alfiah Noor, Kshitiz Singh, Erik Teugels, Gang Chen, Marc Bracke (UGent) and Jacques De Grève

(2015) ONCOTARGET. 6(24). p.20132-20144
Add to list
- Journal Article
- A1
- open access
Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer

Ijeoma Umelo, Amir Noeparest, Gang Chen, Marleen Renard, Caroline Geers, Johan Van Steenkiste, Philippe Giron, Olivier De Wever (UGent) , Erik Teugels and Jacques De Grève

(2015) ONCOTARGET. 7(3). p.3068-3083
Add to list
Mixed adenoneuroendocrine carcinoma of the colon : molecular pathogenesis and treatment

Leen Vanacker, Dominiek Smeets, Anne Hoorens (UGent) , Erik Teugels, Roberto Algaba, Marie Françoise Dehou, Ann De Becker, Diether Lambrechts and Jacques De Greve

(2014) ANTICANCER RESEARCH. 34(10). p.5517-5521

Academic Bibliography

The BRCA1 c. 5096G > A p.Arg1699Gln (R1699Q) intermediate risk variant : breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation : efficacy and safety

Prospective evaluation of first-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation : a multicenter academic phase II study in Caucasian patients (FIELT)

Combined inhibition of rho-associated protein kinase and EGFR suppresses the invasive phenotype in EGFR-dependent lung cancer cells

Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade

Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer

Mixed adenoneuroendocrine carcinoma of the colon : molecular pathogenesis and treatment

Contents

Support

Contact